Navigation Links
National Class Action Filed Against Manufacturer of Digitek(R) (Prescription Drug) in Federal Court in Michigan
Date:7/8/2008

DETROIT, July 8 /PRNewswire/ -- At 12:00 noon on July 8, 2008, J. Douglas Peters, an attorney with Detroit's Charfoos & Christensen, P.C., filed the first drug product liability action in a Michigan Court since the Michigan Supreme Court affirmed former Governor Engler's grant of immunity to drug manufacturers.

The class action drug product liability lawsuit was filed in the United States District Court, Eastern District of Michigan, Southern Division, by plaintiffs Anthony Harris (Redford) and Steven B. Love (Kentwater) against Activis Group (formerly known as Amide Pharmaceutical), Mylan Pharmaceuticals, Inc. and UDL Laboratories, Inc., et al, claiming damages in excess of $75,000.00.

Digitek(R), the trade name for the drug in question, is the brand name for digitalis, a drug given to heart patients. During the manufacturing process, errors were made such that the .125 mg labeled tablet was actually .250 mg; and, the tablet sold as .25 mg was actually .50 mg. This manufacturing error is not covered by the broad grant of immunity Governor Engler intended when Michigan's drug manufacturer immunity legislation was adopted during the Engler Administration.

Death from ventricular arrhythmia, or heart block, can result from digitalis overdose. Non-fatal complications can include nausea, vomiting, severe weight loss, diarrhea, mental confusion, vision changes and elevated blood pressure, which can lead to cerebral strokes.

The filing of this class action lawsuit in Michigan prevents the statute of limitations for other Michigan citizens from expiring. This is helpful because some, but not all recipients of Digitek(R), received letters from their pharmacies recalling the misbranded drugs.

According to Peters, "I sure hope that the manufacturing errors by these major pharmaceutical companies are not given the cloak of immunity by the conservative majority that currently controls the Michigan Supreme Court. To give immunity to manufacturers who do not manufacture their products according to the FDA's standards should be a step too far for even our Supreme Court."

For more information contact J. Douglas Peters or Ann K. Mandt of Charfoos and Christensen, P.C., at 313.875.8080.


'/>"/>
SOURCE Charfoos & Christensen, P.C.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Yakima Health Care Leader Tapped for Leadership Post at National Association
3. Virginia Tech Report Has National Importance
4. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
8. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
9. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
10. LCA Hails International Investigators Studying Lung Cancer
11. National Patient Safety Foundation Partners with Vocera Communications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... ... 06, 2016 , ... Logically, spring weather, with its moderate humidity and temperatures, ... cold, dry or hot, water on the eye surface can evaporate, creating uncomfortable dry ... air. There’s only one problem, according to radio show and water advocate Sharon Kleyne: ...
(Date:5/6/2016)... ... , ... Canadian author Mark Black is a speaker, author, and life strategy coach ... world … with the help of his publisher Strategic Book Group and its subsidiary ... hospital bed waiting for a miracle: He needed a heart and double-lung transplant. From this ...
(Date:5/6/2016)... , ... May 06, 2016 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... worldwide, what he has found in the Bible about helping to stop cancer. Yisrayl says ... it is his hope that the health and science industries will pay close attention and ...
(Date:5/6/2016)... ... 2016 , ... Kenneth Cochran, DSc, RN, FACHE, President/CEO of ... South announced today that Dr. Robert Menuet, Interventional Cardiologist with Cardiovascular Institute of ... Coronary Atherectomy. , This procedure involves the removal of plaque by ...
(Date:5/5/2016)... Tucson, AZ (PRWEB) , ... May 05, 2016 , ... ... more attention being paid to the impact our aging population has on communities and ... help aging adults plan for and face age-related challenges. , Aging Life Care ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... Research and Markets has announced the addition ... EU Markets"  report to their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... the current Positron Emission Tomography (PET) scanner and cyclotron install ... includes France , Germany ... and the United Kingdom . Along ...
(Date:5/4/2016)... Holdings (NYSE: CODI ) ("CODI," "we," "our" ... businesses, announced today its consolidated operating results for the ... Quarter 2016 Highlights , Generated Cash Flow Available ... $13.6 million for the first quarter of 2016; ... first quarter of 2016; , Paid a first ...
(Date:5/4/2016)... JERUSALEM , May 4, 2016 ... University of Jerusalem announced today that it had ... BioTheryX, Inc. , developer of novel protein degradation ... the development and commercialization of drug candidates representing first-in-class ... the license were not disclosed. The novel ...
Breaking Medicine Technology: